Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 265 - 272 of 12004 results

The Future of the Medicare Drug Price Negotiation Program

February 13, 2025| Article| Viewpoint

A Circuit Win and the End of Chevron Deference Could Shift Tides in Drug Price Negotiation Program Challenges

February 13, 2025| Article| Viewpoint

Duplicate Discounts Between the 340B Program & Medicare Drug Price Negotiation Program

February 13, 2025| Article| Viewpoint

The IRA in 2025: The Future of Medicare Part D

February 13, 2025| Article| Viewpoint

From the Desk of ML Strategies: The Medicare Drug Price Negotiation Program Under the Second Trump Administration

February 13, 2025| Article| Viewpoint

Mintz IRA Update — Fourth Edition: Q1 2025

February 13, 2025| Article| Viewpoint

Trump Administration Seeks Public Comments for AI Action Plan — AI: The Washington Report

February 12, 2025| Article| Viewpoint

Watch Your Language! Non-Pro Rata Uptier Transactions and the Serta and Mitel Decisions

February 12, 2025| Blog| Viewpoint

News & Press Releases

Mintz Advises Syntis Bio on $33 Million Series A Financing

July 02, 2025

Mintz advised Syntis Bio, a clinical-stage biopharmaceutical company revolutionizing oral therapies for obesity, diabetes, and rare diseases, on a $33 million oversubscribed Series A financing.

Mintz Obtains Trademark TRO Against OpenAI on Behalf of IYO, Inc.

June 30, 2025

Mintz secured a rare trademark temporary restraining order (TRO) on behalf of IYO, Inc. against OpenAI, Sam Altman, Sir Jony Ive, and IO Products, Inc. The order temporarily bars the defendants from using the trademark associated with their new product launch.

Mintz Advises Brij in $8M Oversubscribed Funding Round

June 26, 2025

Mintz advised Brij—a software platform enhancing the consumer experience by bridging online and offline commerce—on the closing of its $8 million Series Seed round. The funding will help Brij advance its mission to close the trillion-dollar disconnect between brands and their retail customers and power the next generation of offline-to-online customer relationships.

View all News and Press Releases